GRAVES’ DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Global Graves’ Disease Market, By Disease Type
     • Global Graves’ Disease Market, By Symptom
     • Global Graves’ Disease Market, By Diagnostic Method
     • Global Graves’ Disease Market, By Treatment Modality
     • Global Graves’ Disease Market, By End User
     • Global Graves’ Disease Market, By Distribution Channel
     • Global Graves’ Disease Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Market Opportunities
   • Regulatory Scenario
   • Key Developments
   • Industry Trends

4. Global Graves’ Disease Market, By Disease Type, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Overt Graves’ Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Subclinical Graves’ Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Graves’ Disease Market, By Symptom, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Thyrotoxicosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Graves Orbitopathy (Ocular)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Dermopathy (Pretibial Myxedema)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Other Systemic Manifestations
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Graves’ Disease Market, By Diagnostic Method, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Clinical Evaluation
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Imaging
   • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Ultrasound
       • Radioiodine Uptake Scan
       • MRI/CT (for orbitopathy)
   • Laboratory
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • TSH
       • Free T3/Free T4
       • TSH Receptor Antibodies (TRAb)

7. Global Graves’ Disease Market, By Treatment Modality, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Pharmacological
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Antithyroid Drugs
         • Methimazole
         • Propylthiouracil
         • Carbimazole
       • Beta Blockers
       • Corticosteroids
       • Immunosuppressants
   • Radioactive Iodine Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Surgical
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Total Thyroidectomy
       • Subtotal Thyroidectomy
   • Adjunctive/Ocular
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Orbital Decompression
       • Rituximab
       • Teprotumumab
   • Supportive/Other
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
       • Lifestyle/Adjunctive Care

8. Global Graves’ Disease Market, By End User, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Specialty Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Diagnostic Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Ambulatory Surgical Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Home Care Settings
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Graves’ Disease Market, By Distribution Channel, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

10. Global Graves’ Disease Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Symptom, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Diagnostic Method, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa

11. Competitive Landscape

    • Pfizer Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co. Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Graves’ Disease Market' - Global forecast to 2033